Skip to main content

Table 4 Percent cell cycle distribution of GemHCl and 4NSG-SLN in PPCL-92 and PPCL-46 cells

From: Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer

Cell line

 

GemHCl

4NSG-SLN

%G1

%S

%G2

%G1

%S

%G2

PPCL-192

Control (untreated)

66.47

11.07

18.46

58.75

11.07

18.46

5 μΜ

71.08

17.87

11.05

80.57

12.22

7.21

10 μM

74.75

15.66

9.59

83.25

11.44

5.31

20 μM

79.91

11.86

8.23

90.45

6.37

3.18

PPCL-46

Control (untreated)

68.75

10.90

20.35

68.75

10.90

20.35

5 μΜ

72.75

14.69

12.56

78.25

11.61

10.14

10 μM

74.08

15.53

10.39

82.12

10.49

7.39

20 μM

76.35

14.11

9.54

87.53

10.02

2.45

  1. Data represent ± SEM, n = 3